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Antibodies formed in response to injection of single antigens may be extra- 
ordinarily heterogeneous, often consisting of molecules belonging to each of the 
three major classes of serum immunoglobulins, "yG, "yM,  and  TA  x (1-3). Me- 
Duffle, et al.  (7), studying the properties of human blood group isoantibodies, 
showed that rabbits immunized with specific precipitates of A  substance and 
human anti-A developed antibodies to three serum proteins; two of these were 
identified as antibody to "yG- and "yM-immunoglobulins. The third protein re- 
mained unidentified until it was characterized by Kunkel and Rockey (8)  as 
"yA. Serum from individual human donors may contain anti-A or anti-B of all 
three immunoglobulin classes (8-10). 
It would be of great interest to determine the characteristics of the combining 
sites of the various anti-A immunoglobulins formed in a single individual. The 
present study reports a new method for purifying anti-A or anti-B using specific 
insoluble adsorbants, separation of the purified anti-A antibodies into "yG- and 
,yM-fractions,  and  initial  observations  on  the  relative  capacities  of  various 
oligosaccharides involved in the A antigenic determinant to inhibit the precipi- 
tation of TG- and ~M-anti-A by blood group A  substance. 
Materials and Metkods 
Blood Group Substances.--Soluble blood group substances were purified from bog gastric 
mucin, (Wilson Laboratories, Chicago), and human ovarian cysts by previously described 
* Aided by grants  from the National  Science Foundation  (G-18727 and  GB-3675), the 
Office  of Naval Research, The National Heart Institute (HE 04456 and 5488), and the General 
Research Support grant of the United States Public Health Service. 
Present address: The Department of Medicine, Jewish Hospital of St. Louis, St. Louis. 
1  The nomenclature used is that recommended by the World Health  Organization (4). 
"yD (IgD), recently described by Rowe and Fahey  (5), has not yet been shown to exhibit 
antibody activity (6). 
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methods  (11).  Insoluble derivatives of these purified blood group substances were prepared 
by  copolymerization with  the  N-carboxyanhydride  of L-lencine  as  described  by Tsuyuki, 
et al. (12). 2 The details of this procedure were as follows:  Purified blood group substance was 
dissolved to a  concentration of 4  mg/ml in 7A00 M NaHCO3 (pH 8.3).  The solution in an 
Erlenmeyer flask was  chilled to  approximately  5°C  and  mixed continuously  by  magnetic 
stirring. To it was slowly added solid crystalline N-earboxy-L-leucine anhydride (Pilot Chemi- 
cals, Inc. Watertown,  Massachusetts)  in an amount equal to the weight of dissolved blood 
group substance.  Stirring in the cold was continued for an additional 48 hr. The contents of 
the flask were then centrifuged for 1 hr at 17,000 RP~ in a refrigerated Servall RC-2 centrifuge. 
The  dear  supernatant  solution was  decanted,  the  precipitate  thoroughly  dispersed  in  25 
volumes of ~0 o x( NaHC08 and again centrifuged. This step was repeated until the precipitate 
had been washed 4 times in NaFICOa and 4 times in distilled water. After the last wash the 
precipitate was lyophiliz~d  and stored at room temperature. The  insoluble blood group ma- 
terials so prepared are, hereafter, referred to as polyleucyl blood group substances  (PI-BGS) 
and as polylencyl A (P1-A) and polyleucyl B  (P1-B). 
Inhibitors.--Haptenic  derivatives of purified human  ovarian cyst A  substance  were pre- 
pared by mild acid hydrolysis (13) and by alkaline cleavage in the presence of sodium bore- 
hydride (14). Two oligosaccharides,  A~I (13), a trisaccharide having the structure: 
c~-,-GalNAc-(1 ~  3)-~-D-Gal-(1  ~  3)-D-GNAc 
and ARL 0.52  (previously called Aa) a pentasaccharide with the structure: 
cz-L-Fuc 1 
1 
2 
Ot-D-GalNAc-(1 ~  3)-f~-D-Gal-(1 ---)  4)-f~-D-GNAc-R 
representing  the largest  and  most  active fragment  of the  antigenic determinant  of blood 
group A substance thus far isolated (15-17)  were utilized along with N-acetyl-v-galactosamine 
(GalNAc)  to inhibit  the precipitation of the purified  anti-A by A  substance  as  described 
earlier (18, 19, 13)? 
Antiscra.--Serum  R.G.,  generously  provided  by  Dr.  Richard  E.  Rosenfield  of  Mount 
Sinai Hospital, New York,  was obtained from a  multiparous  blood group O  female hyper- 
immunized by repeated blood group A pregnancies. Two separate bleedings from this donor 
were obtained,  the  first  (R.G.I)  dating from June,  1959, and  the  second  (R.G.II)  from 
February, 1962. Serum Ortho 63-2622 was the gift of Dr. Philip Levine and Mr. Glen Hill of 
Ortho Research Laboratories,  Raritan,  New Jersey.  The donor of this serum was a  blood 
group B individual immunized with hog A substance. These sera were preserved with phenol 
(0.25%) and merthiolate (1:10,000)  and were stored at 4°C. Goat and rabbit antisera to whole 
human  serum  and  to  human  7G-,  7A-,  and  7M-immunoglobulins  were  purchased  from 
Hyland Laboratories, Los Angeles,  and from Lloyd Bros., Inc., Cincinnati. Rabbit antisera 
specific for human kappa (group I) and lambda (group II) polypeptide chains were the gift of 
Dr. Henry Kunkel of The Rockefeller University. Dr. John Fahey of the National Institutes 
of Health generously furnished rabbit antiserum to human 7D and serum W.T., a serum con- 
mining known quantifies of'yD. Antisera specific for human complement components C'q and 
~IC/~IA were kindly supplied by Dr. Charles Christian and Dr. Konrad Hsu of the College 
of Physicians and Surgeons. 
2 We are  indebted  to  Dr.  Lawrence  Levine of Brandeis  University who  suggested  the 
possible applicability of this method. 
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Carbohydrates.--v-Galactose  and  sucrose  were  purchased  from  Pfanstiehl  Chemicals, 
Waukegan,  Illinois,  and  N-acetyl-v-galactosamine  from  Nutritional  Bioehemicals  Corp., 
Cleveland. Biogel P  10 and P 300 used for gel filtration were obtained from Bio-Rad Labora- 
tories, Richmond, California. 
Analytical  Me/hods.--Standard analytical techniques were utilized and the following sub- 
stances measured by the methods given: methylpentose,  Dische and  Shettles; hexosamine, 
E]son and Morgan; and reducing sugar, Park and Johnson (d. 18). The procedure for nitrogen 
was a modification (14) of the method of Rosevcar and Smith (20). 
Separation  Procedures.---Gel filtration employing Biogel P  10  and  P  300  columns was 
carried out at room temperature according to the directions supplied by Bin-Rad Laboratories. 
Density gradient ultracentrifugation was performed as described by Kunkel (21) utillzi~g 
a 4 mi linear (10 to 40%) sucrose gradient in a Spinco model L centrifuge with SW 39 rotor 
for 16 hr at 35,000 m,x~.4 Ten fractions of equal volume (circa 0.45 ml) were collected drop- 
wise through a pin hole made in the bottom of the tube. 
Immunochemical  Methods.--Hemagglutination  studies  were  performed  with  a  Takatsy 
microtitrator (Cooke Engineering Company, Alexandria, Virginia) using 0.025  nil loops and 
2% erythrocyte suspensions at room temperature. 
Quantitative precipitin analyses (18) were performed by a micropreeipltin technique using 
the ninhydrin procedure for nitrogen (14). 
Agar diffusion  studies were carried out at 37°C according to the method of Ouchterlony 
(22) in 1% gels (Ionagar No. 2, Consolidated Labs., Inc., Chicago) containing 0.5 M glycine 
(23) and 1:10,000 merthiolate. 
Immunoelectrophoresis was performed as described by Grabar and Williams (24)  (d. 25). 
Puri  fwation of Isokemagglutinins.--The  principle of the method involves the specific  ab- 
sorption of anti-A or anti-B antibodies by P1-A or PI-B respectively, removal of nonspecific 
protein by washing, and elution of absorbed antibody by extraction with acid buffer or with 
sugar haptens at neutral pH. The specific procedure was as follows: 
Absorp¢ion: To a  given volume of serum containing anti-A was added  I  mg/mi of P1-A. 
The serum was thoroughly mixed to suspend the insoluble material evenly, and incubated at 
37°C for 1 Jar with frequent mixing. The serum was then slowly rot&ted  (10 to 16 RiM) for 1 
wk in the refrigerator. The insoluble P1-A was harvested by eentrifugstion and the superuatant 
serum tested for residual anti-A by hemagglutination and by quantitative precipitin tests. 
It was invariably found that more than 90% of the homologous antibody had been removed 
by the PI-A. With R.G., a type  O serum which contained both anti-A and anti-B, absorptions 
were performed in 2 different ways: in the first instance the serum was absorbed only with 
P1-A; in the second experiment sequential absorptions with P1-B followed by P1-A were carried 
out. 
After absorption,  the P1-BGS-antibody complex was washed repeatedly with cold saline 
until the washings were essentially devoid of material absorbing at 2800 A. 
Elution:  Elution of antibody was performed by suspending the packed, washed P1-BGS- 
antibody precipitate in 2 ml, ~/10 acetate buffer, pH 3.62 at 0°C (26), for I hr with frequent 
mixing. After eentrifugation at 4°C, the supernatant was immediately transferred to a dialysis 
casing unknotted at the top and dialyzed against 500 nil cold PO4-buffered  saline (~/20, pH 
7.3).  Fresh, cold acetate buffer (pH 3.62)  was rcapplied to the packed sediment and the ex- 
traction repeated. The second eluate was added to the first in the dialysis bag, and the dialysis 
fluid changed. A third ehition was performed and the P1-BGS washed several times with small 
quantities of saline.  The combined eluates and saline washes were dialyzed for 6 hr against 1 
4 We gratefully acknowledge the expert assistance of Dr. K. Aho in the performance of 
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liter of ,~/20 PO4-buffered  saline (pH 7.3) and overnight against xr/1000, PO4-buffered saline 
(pH 7.3). Since the antibody yield by acid elution did not exceed 10%, the procedure was 
changed as follows: washed, packed H-A that had been used for anti-A absorption was sus- 
pended in 2 to 3 ml of PO4-buffered saline (M/1000, pH 7.2-7.3) containing 1 g of GalNAc, 
incubated for 1 hr at 37°C, and slowly rotated overnight in the refrigerator. Mter centrifuga- 
tion, the supematant eluate was removed and the P1-A resuspended in additional GalNAc in 
buffered saline. This procedure was repeated twice and the resultant eluates pooled. The H-A 
was washed several times in cold, buffered saline and the washings added to the pooled eluates. 
The elution procedure for H-B was identical to that for PI-A except that ,-galactose  was 
substituted for GalNAc. The pooled eluates and washings were concentrated by ultrafiltration 
in the cold under negative pressure through an 8 ml collodion membrane, porosity less than 
5 n~u (Membranfiltergesellschaft  G6ttingen, Germany, obtained from Schleicher and Schuell, 
Keene, New Hampshire). Initially, the concentrated, sugar-containing eluates were freed of 
TABLE I 
AnalyHcal Properties of Purified Blood Group Substances and of Their 
Insoluble Polyleucyl Derivatives 
Material  Methylpentose  Hexosamine 
Hog A 
H-hog A (I) 
m-hog A (II) 
McDon A 
H-McDon A 
Beach B 
H-Beach B 
%  % BGS 
10.6  100 
5.8  55 
6.0  57 
21.1  100 
7.6  36 
19.3  100 
8.7  45 
% 
29.0 
16.3 
15.3 
30.9 
11.1 
21.3 
9.4 
% BGS 
100 
56 
53 
100 
36 
I00 
44 
sugar by repeated cycles of dilution with buffered saline and ultrafiltration. More recently it 
was found by Dr. Marianne M. Dorner in this laboratory, that a single passage of such a con- 
centrated  eluate  through  a Biogel P-10 column  (I.1  X  60 cm) equilibrated with buffered 
saline (~r/1000, pH 7.2) served to separate completely hapten (i.e. sugar) from protein. Those 
chromatographic fractions absorbing at 2800 A were pooled and reconcentrated  by ultra- 
filtration. 
R.ESUI,TS 
Preparation of and A bsorption with Insoluble Blood Group Substances.--Table I 
summarizes the analytical properties of the original purified blood group sub- 
stances and of their insoluble polyleucyl derivatives. Two separate  batches  of 
Pl-hog A  (I and II) were prepared from the same starting materials. When the 
methylpentose and hexosamine contents of the various polyleucyl compounds 
are  expressed as  percentages of  those  found in the  parent blood group  sub- 
stances, it is apparent that the insoluble derivatives contained from 36 %  (PI- 
Beach B) to about 55 %  (Pl-hog A) of blood group material. MANUEL  E.  KAPLAN  AND  ELVIN  A.  KABAT  1065 
The capacities of the polyleucyl blood group substances to absorb specifically 
anti-A and anti-B from human sera is illustrated in Table II. Absorption of 
R.G.I, which contained both anti-A and anti-B, with Pl-hog A was found to re- 
move 95 % of the anti-A (22 of 23 #g Ab (antibody) N/ml) and about 75 % of the 
anti-B (3.6 of 4.7 #g Ab N/ml). The absorbed serum agglutinated type B cells 
to a  titer of 1:16 but,  even undiluted,  would no longer agglutinate  type A1 
erythrocytes. P1-McDon A absorbed from serum R.G.I more than 95 % of the 
antibody N  which McDon A was capable of precipitating (13.5 of 14.0 #g Ab 
N/ml). This represented only about 3/~ of the total anti-A precipitable by hog 
mucin A. P1-A absorption removed most of the anti-B from R.G.I as well. 
TABLE H 
Absorption of Anti-A and Anti-B by Insoluble Polyleucyl Blood Group Substances 
Antiserum 
R.G.I 
Unabsorbed 
Absorbed with Pl-hog A 
Absorbed with P1-McDon A 
R.G.II 
Unabsorbed 
Absorbed with H-Beach B 
Absorbed with PI-Beach B +  H-hog A 
Ortho 63-2622 
Unabsorbed 
Absorbed with Pl-hog A 
Hemngglutinafion 
titer 
A cells  B cells  Hog A 
~g/ml 
128  32  23.0 
0  16  1.0 
2  16  5.0 
128  32  18.4 
64  0  17.1 
0  0.5 
256  0  13.3 
0  0.9 
Antibody  N precipitated  by 
McDon A  Beach B 
14.0  4.7 
0.7  I.I 
0.5  1.8 
4.7 
0.2 
Serum R.G.II,  containing 20% less anti-A than R.G.I, was  absorbed first 
with PI-Beach B  and then with Pl-hog A. The first absorption removed more 
than 95 % of the antibody N precipitable by human B substance, (4.5 of 4.7 #g 
Ab N/re_l)  but less than 10% of the Ab N  precipitable by hog A  (1.3 #g of a 
total of 18.4 #g Ab N/ml). The rest of the anti-A was removed by a  subse- 
quent absorption with PI-A. These findings indicate that in serum R.G., AB 
cross-reacting antibody makes up a large proportion of the anti-B and only a 
small proportion of the anti-A. 
Purification and Characterization  of Blood Group Antibodies.--Table III sum- 
marizes the absorption and elution steps used in isolating anti-A and anti-B, 
the yields obtained, and the agglutinating and precipitating properties of the 
purified  antibodies.  In  the  initial  study  suboptimal  quantities  (0.5  mg/ml 1066  HUMAN  ANTIBODIES.  IV 
serum) of P1-A were used for absorption, and elution was performed with pH 
3.62  acetate buffer. An overall anti-A yield of only 7.3 % was achieved. Subse- 
quently, antibody recoveries were improved by absorbing with larger quantities 
of P1-A and eluting with GalNAc at neutral pH. 
Both the acid and GalNAc eluates prepared from P1-A-R.G.I antibody com- 
plex agglutinated type B cells to a modest titer, 1:16; however, neither eluate 
was precipitated by human B substance. 
In an attempt to isolate AB cross-reacting antibody from serum R.G.II, the 
latter  was  absorbed  with  P1-B and  elution  carried  out  with  galactose,  the 
terminal nonreducing sugar of the B  antigenic determinant (19,  27).  The re- 
TABLE III  Preparation and Properti 
Serum 
R.G.I. 
R.G.I. 
R.G.II 
Ortho 63-2622 
Volume 
used 
ml 
12~ 
4.  ¢ 
(a)  16( 
(b)  15C 
223 
Total  antibody  N 
Anti-~ 
2875 
1035 
2950 
2565 
2990 
Anti-] 
~g 
563 
212 
768 
38 
Absorbant 
Pl-hog A* 
P1-hog A 
P1-Beach B 
Pl-hog A 
P1-hog A 
Absorption 
Residual  antibody  N 
Anti-A  Anfi-B 
~g  go  J*g 
688  24  N.D.~ 
45  4  45.2 
2735  93  40 
75  3  N.D. 
214  7 I 
% 
21 
5 
*  In this  instance only 0.5 mg  Pl-hog  A/ml  serum was used for absorption which a 
counts for the incomplete removal of anti-A. 
:~  Not determined. 
sultant eluate, although relatively poor in nitrogen, agglutinated type A and B 
erythrocytes to fiters of 1: 256 and was incompletely precipitated by both A and 
B substances. Since no effort was made to differentiate the anti-B from anti-A 
B, it is not possible to relate, quantitatively, the N  content of this eluate to the 
anti-A or anti-B  present in  the  original serum.  Efforts to  obtain  additional 
antibody from the P1-B substance by elution with galactinol were unsuccessful. 
Fig.  1 A  and 1 B  demonstrate that P1-A-GalNAc  eluates from R.G.II and 
Ortho 63-2622  contained q,G-, 3'M-, and q,A-immunoglobulins.  (All  three im- 
munoglobulins were also detected in the P1-B-Gal eluate from serum R.G.II.) 
When  the  immunoelectrophoretic patterns  were  developed  with  polyvalent 
goat anti-human serum, some of the eluates were found to contain trace quanti- 
ties of albumin; furthermore, the Ortho eluate gave an additional very faint 
band in the slow/~-region close  to, but separate from, the ~/M-line.  The sub- MANUEL  E.  KAPLAN  AND  ELVIN  A.  KABAT  1067 
stance responsible for the "extra" precipitin band is unknown, This eluate was 
tested for ~,D  (Fig.  1 C)  and complement components C'q and/~IC//~IA, but 
they were not found. 
Fig. 1 D  demonstrates the precipitation in agar gel of hog and human A blood 
group substances by the concentrated R.G.II anti-A eluate. A continuous arc of 
precipitation, without spurring,  developed (wells 1 and 6). This indicates that 
although in  the cold hog A  precipitated 40% more  AbN from serum R.G.II, 
than did McDon A, with respect to the antibodies present in this anti-A eluate, 
hog A  and McDon A substances are antigenically indistinguishable  within the 
sensitivity  of  the  agar  diffusion  method.  The  precipitin  lines  formed by  the 
[nti-A and Anti-B Eluates 
Elution  ]  Eluate 
Eluant 
t 3.62 
~nAc 
I 
~lactose 
~tNAc 
~.tNAc 
Total 
#g 
306 
351 
143 
1279 
2128 
N  re- 
covery 
% 
11 
34 
? 
50 
71 
Ab N 
pptable 
y A subst. 
~g 
209.5 
254 
38.4 
910 
1125 
Ab N 
pptabl¢ 
% 
69 
72 
? 
71 
53 
Reco- 
very of 
Anti-A 
% 
7 
25 
? 
34 
38 
I 
Ab N  lAb N 
pptable  [  pptable 
b  B  -- 
su~st,  fctal N 
ug  I  % 
0  0 
0  0 
39.3  ? 
0  0 
Reco- 
very of 
anti-B 
% 
0 
0 
Hemagglutina- 
tion titer 
A ceils  B cells 
512  16 
256  16 
256  256 
1280  0 
5120 
eluate and anti-3,G,  anti-'yM, and anti-~,A all penetrated  the  A-anti A  band. 
The latter, in turn, spurred through the anti-3,M- and anti~,A but not through 
the  anti-TG-lines. These findings indicate  that  the R.G.II anti-A eluate con- 
tains molecules of each immunoglobulin class not precipitable by A  substance 
in agar at 37°C.  In contrast,  quantitative precipitin studies performed at 0°C 
showed the  eluate to be 75 %  precipitable by A  substance.  The failure of the 
A-anti A  band to penetrate the eluate-anti-3,G-precipitin line may reflect the 
reactivity of the  unabsorbed  anti-~/G-serum with L  chain determinants  com- 
mon to all three immunoglobulin classes (2). 
Fractionation of Purified Blood Group Antibodies.-- 
Ortho  eluate:  An aliquot containing  1735 #g N, of the Ortho eluate was con- 
centrated to 1.5 ml and 150 mg of crystalline sucrose added. The solution was 
layered  at  the  liquid-gel  interface  of a  20  X  700  mm Biogel  P-300  column, 
equilibrated  at  room  temperature  with  M/3.3  buffered  saline,  pH  7.4.  1  ml Fro. 1. A. Immunoelectrophoretic patterns of (1) Ortho 63-2622 serum, (2) Ortho-GalNAc 
eluate, (3) R.G.II serum, and (4) R.G.II-GalNAc eluate; goat anti-human serum was used in 
the troughs to develop reactions. 
B.  Immunoelectrophoretic patterns of  (1, 4)  Ortho 63-2622 serum; (2, 3)  Ortho-GalNAc 
eluate;  (5,  8)  R.G.II serum; and  (6,  7)  R.G.II-GalNAc eluate; troughs  (a)  goat anti-TG- 
globulin, (b) goat anti--TA-globulin, and (c) goat anti-"/M-globulin. 
C.  Center well:  rabbit anti-TD-serum. Peripheral wells,  (1)  empty,  (2)  Ortho  63-2622 
serum, (3) Ortho-GalNAc eluate, and (4) W.T. serum ('yD-standard). 
D.  Center well: R.G.II-GalNAc eluate. Peripheral wells, (1) McDon A substance, (2) goat 
anti-TM-globulin, (3)  goat  anti-/A-globulin, (4)  McDon  A  substance,  (5)  goat  anti-'yG- 
globulin, and (6) hog A substance. 
E.  Immunodiffusion study of ten fractions resulting from density gradient centrifugation 
of R.G.II-GalNAe eluate. Trough (a) goat anti-'yM-globulin, (b) goat anti-TA-globulin  , and 
(c) goat anti-TG-globulin. 
F.  Center well (a): rabbit anti-type K  (group  I) antiserum. Center well (b): rabbit anti- 
type L  (group  II) antiserum. Peripheral wells,  (1)  type K  Bence-Jones protein,  (2)  R.G.II 
"),G-fraction, (3) R.G.II "/M-fraction, (4) type L Bence-Jones protein, (5) Ortho "yM-fraction, 
and (6) Ortho ~/G-fraction. 
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fractions were collected at the rate of 18 per hour and their absorbance at 2800 A 
measured.  The absorption curve showed  two  broad,  incompletely separated 
peaks. The immunoglobulins present in selected fractions were characterized by 
means of agar diffusion employing 3'M-, "yG-, and ^/A-specific antisera. Second 
peak fractions 68 to 137 containing "yG and very small amounts of yA, were 
pooled, dialyzed against  isotonic buffered saline,  and concentrated by ultra- 
filtration to give the "yG-fraction of the Ortho eluate. Fractions 33 to 55, which 
represented the ascending limb of the first protein peak, were found to be pre- 
ponderantly ~/M;  however, after these fractions had been pooled and concen- 
trated, trace quantities of ~,G and "yA were detected. Consequently, P-300 gel 
filtration was repeated under the conditions previously described. Only a single 
TABLE IV 
Properges of the Unfractiona~t Anti-A eluates and  f Tlwir Separated 'yG-and "yM- Fracffons 
I 
Ab N  lab  s  Anti-A 
OD  OD 2800 A  pptable  [ pptable  hemag- #gN/m] 
Eluate  Nitrogen  2800 A  #g N/ml  ;by A  I  gluti-  subst.  I  total N  nation  tlter 
titer 
)rtho unfractionated* 
~,G-fraction 
~/M-fraction 
R.G.II unfractionated 
3,G-fraction 
TM-fraction 
Intermediate fraction 
Pg 
180 
625 
94 
985 
498 
112 
15 
pg/~ 
90.2 
68.7 
62.8 
365 
148.8 
34.1 
12.7 
0.890 
0.655 
0.520 
I~.D. 
1.492 
0.440 
0.141 
0.00987 
0.00953 
0.00829 
N.~D. 
0.0103 
0.129 
0.111 
~tg 
91.4 
326 
40.7 
702 
343 
99.5 
10.7 
% 
51 
52 
43 
71 
69 
89 
71 
320 
320 
160 
5120 
5120 
80 
80 
0.28 
0.21 
0.39 
0.07 
0.03 
0.43 
0.16 
* This represents a dilution of a small portion of the Ortho eluate not subjected to gel 
filtration. 
protein peak containing essentially pure ~M resulted. Fractions 56 to 67 of the 
first F-300 co|utah were found to consist of mixtures of all three immunoglobulin 
classes and were not further studied. 
R.G.II duale: An aliquot of this eluate, contninlng 985 pg N,  was  concen- 
trated to 0.5 ml, layered on a  4 ml sucrose density gradient, and centrifuged 
for 16 hr at 35,000 m~ as previously outlined. Ten 0.45 ml fractions were col- 
lected and the immunoglobulin content of each fraction determined  by agar 
diffusion (Fig. 1 E). Fractions 1 and 2 consisting almost exclusively of ~/M, and 
fractions 4  to 6  containing ~/G- and some 5,A-immunoglobulins were pooled. 
These 2 fractions, as well as fraction 3, which represented a mixture of -IM, ~/G, 
and ~,A, were dialyzed thoroughly against buffered  saline to remove sucrose. 
The immunochemical properties of these fractions,  designated,  as R.G.  -yM 
(tubes  1 and 2), "yG (tubes 4  to 6),  and intermediate (tube 3)  were studied 
without further fractionation. 1070  HUMAN  ANTIBODIES.  IV 
Table IV summarizes the analytical data on the purified  fracfionated  anti- 
bodies  and  Fig.  2  depicts  their  precipitation  curves  with  hog A  substances. 
Total N  recovery from  the R.G.II eluate  was 64% with 51% in the ~¢G-frac- 
tions, 11.4% in the ~,M-fraction, and 1.5 % in the intermediate fraction. From 
its  absorbance  at  2800  A,  the intermediate  Ortho fraction was  estimated  to 
contain 148 #g N; thus, an overall N  yield of only 50% was achieved from the 
Ortho eluate.  This  comparatively  poor recovery may  be  ascribed  to protein 
denaturation due to prolonged exposure of the Ortho eluate to summer  room 
temperatures  (28--32°C) during gel filtration. 
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FIG. 2. Quantitative precipitin curves of whole anti-A eluates and their 3'M- and "yG- 
fractions. 
When the N  content and absorbance at 2800 A  of the individual antibody 
solutions are compared (Table IV, column 4), it is apparent that the value for 
OD/~g  N  obtained  for  the  two  ~'M-fractions  deviate  appreciably,  and  in 
opposite directions, from the ~G-values. 
Precipitability of the Ortho eluate and its fractions by hog A substance was 
rather low (43 to 52 %) while that of the R.G.II  eluate and its fractions was 
higher, ranging from 69%  (~G) to 89%  (~M). The A-anfi-A precipitin curves 
for each eluate and its constituent immunogtobulin fractions (Fig. 2) were very 
similar and did not deviate in shape from the  classical  quantitative  precipitin 
curve  • 
When hemagglutinating activity was expressed as the minimum amount of 
antibody in tzg N/ml required to give detectable agglutination (Table IV, last MANUEL  E.  KAPLAN  AND  ELVIN  A.  KABAT  1071 
column), the R.G.II eluate was four times as active as the Ortho eluate, the 
R.G. ~/G-fraction seven times as active as the Ortho ~,G-fraction, while the ac- 
tivities of the two "rM-fractions were essentially equal. The agglutinating ac- 
tivities of the Ortho antibody fractions were very similar. Much greater differ- 
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FIG. 3. Inhibition by oligosaccharides  of the precipitation by A substance of Ortho anti-A 
and its purified antibody fractions. 
ences were found with the various R.G. fractions (e.g. 0.43 pg N/ml of the 
R.G. ~M-fraction as compared with 0.03 pg N/ml of the -),G-fraction were re- 
quired for detectable agglutination.) 
Fig. 1 F demonstrates that the Ortho 3'M- and 3'G-, as well as the R.G. 3~M-, 
fractions contained both type K  and L  light chains.  Although no effort was 
made to quantitate these determinants, the appearance of the various precipitin 
bands  suggested  that  the two Ortho fractions contained a  preponderance of 
type L  molecules while type K  molecules appeared in somewhat greater con- 1072  HUMAN  ANTIBODIES.  IV 
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centrafion in the R.G. ~M-fracfion. As seen in Fig.  1 F, the Ortho K-anti K 
lines and the L-anti L line developed by the R.G. ~M fraction appeared rela- 
tively close to the antigen (i.e. immunoglobuHn) wells and were quite broad 
and diffuse;  the  diffuseness was  particularly striking on those  sides  of the 
precipitin bands facing the antigen wells. These findings are typical of immuno- 
diffusion precipitin systems containing gross antibody excess (28, 29). The R.G. 
^/G-fraction was found, in contrast, to be comprised almost exclusively of group 
K molecules. Only after prolonged incubation of the gel-diffusion plate did an 
extremely faint precipitin line develop between  the R.G. "yG-fraction and the 
anfi-L serum. This line is not visible in Fig. 1 F. 
TABLE V 
Millimicromoles of Inhibitor Required  for 50°/o Inhibition 
Anti-A 
Ortho 
Serum 
Eluate 
"yG 
~/M 
R.G.II 
Serum 
Eluate 
~/G 
~,M 
Iahibitor 
GalNAc 
2,600 
5,000 
13,000 
2,800 
25,000 
12,000 
4,700 
4,100 
ASH (Trlsaccharlde) 
230 
420 
350 
2800 
1200 
? 
4700 
4100 
IARL 0,52 (Pentasaccharide, 
150 
120 
76 
? 
33 
60 
44 
>300 
Precipitln-Inhibition  Stud/es.--The  behavior  in  quantitative  hapten  in- 
hibition studies of the Ortho and R.G.II sera, the anfi-A eluates and their "),C~ 
and ~M-fracfions is seen in Figs. 3 and 4 and is summarized in Table V. With 
both sera the pentasaccharide  ART. 0.52 was, on a molar basis,  a  far better 
inhibitor than the monosaccharide  GalNAc; the trisaccharide  (A5II) displayed 
intermediate activity. Similar results have previously been reported from this 
laboratory with other anfi-A sera (17). Compared with serum R.G., the Ortho 
serum was considerably more inhibitable by GalNAc and ASII and slightly less 
inhibitable by ARL 0.52. The unfracfionated Ortho eluate was somewhat less 
inhlbitable by GalNAc  and more  inhlbitable  by ARL 0.52 than the original 
serum; the converse findings were noted in the case of serum R.G. and its eluate, 
i.e. the eluate was slightly more inhlbitable by GalNAc and less inhlbitable by 
ART. 0.52 than the original serum. In relatively low concentrations,  the penta- 
saccharide  effectively inhibited the precipitation of both Ortho and R.G. "yG- 
fractions (50 % inhibition being achieved with 76 m~ and 44 m~  respectively). 1074  ~uMAN  ANTIBODIES.  IV 
In contrast, even at ART. 0.52 concentrations of 270 m~,  less than  15 % in- 
hibition of precipitation of the "},M-fractions could be achieved. Although in- 
hibition points at higher  oligosaccharide  concentrations were not obtained be- 
cause of limited material,  the  available data suggest that,  on a  molar  basis 
(a) with both 3,M-anti-A fractions'the penta- and trisaccharide were only as 
efficient  as  GalNAc in inhibiting  precipitation,  (b) with R.G. 3'G the  trisac- 
charide and  GalNAc were only ~0oo as active as the pentasaccharide in in- 
hibiting precipitation  (approximately 4700 m#•  of the first two and 44 m#M 
of the last being required for 50% inhibition),  and  (c) with  the Ortho ~/G- 
anti-A,  the pentasaccharide  was approximately 4  times as active  as  the  tri- 
saccharide which in turn was 40 times more active than GalNAc in inhibiting 
precipitation  (50%  inhibition  points being obtained at  concentrations  of 76 
m/zM, 350 m~,  and 13,000 muir respectively). 
DISCUSSION 
Antigens rendered  insoluble  by various means have  been successfully em- 
ployed as specific immune  absorbants to purify homologous antibodies from 
serum (30, 31, cf. 18). Earlier efforts to isolate human blood group antibodies 
employing this technique were reported by Isliker (32) and by Goodman (33) 
who utilized red cell stroma coupled respectively to ion exchange resins and to 
polyurethane. Although they presented no data regarding the physicochemical 
properties of the recovered antibodies or the degree  of purification  achieved, 
this approach appeared to offer sufficient promise to merit further investigation 
especially in view of the successful  use of Sephadex,  an insoluble dextran,  in 
purifying antidextran (25). 
The  studies herein  reported  clearly show that  specific insoluble  BGS  are 
simply prepared by utilizing  soluble blood group substances as multifunctional 
initiators for the polymerization of N-carboxy-L-leucine  anhydride. The initial 
reaction is schematically depicted as follows: 
H,C\  CH, 
~H,+ (H,N),--BGS 
o 
HsC\  CHa 
Blood group substances, represented as BGS (NI-I~) are mucopolysaccharides; 
the carbohydrate moieties of which contribute approximately 75 to 80% of the 
weight and  antigenic specificity,  are bound to peptides that  are,  apparently, 
immunologically inert  (34).  N-Carboxy-L-leucine  anhydride  reacts  with  free 
amino  groups,  present  as  the epsilon  amino  groups  of lysine  in  the peptide 
portion of the BGS molecule,  all of the amino sugars being N-acetylated. The MANUEL  E.  KAPLAN  AND  ELVIN  A. KABAT  1075 
hypothetical intermediate  product  (*)  resulting  from  the  interaction  of  1 
molecule of carboxyanhydride with 1 molecule of BGS contains (n -  1) lysyl 
amino groups and a newly formed NH2 group on the a-carbon of the attached 
leucine. Additional carboxya~hydride  may then react at these sites to propagate 
the  reaction.  The final insoluble  product is  ~lmost  certainly heterogeneous, 
probably consisting  of polyleucyl chains  of various lengths attached to lysyl 
residues. If polymerizatiou occurs as outlined, the primary structure of anti- 
genically active sites should be undisturbed. The ability of these insoluble BGS 
to combine  specifically with blood group  antibodies  (Table  II) supports this 
concept. 
The immunochemical properties of the various soluble blood group substances 
and of their polyleucyl  derivatives were found to be very similar. Thus, McDon 
A and P1-McDon A were capable of combining with less R.G. anti-A than were 
hog A or Pl-hog A. Such differences have been found  with anti-A sera obtained 
from individuals hyperlmmunized with hog A substances  (11) but have not 
been seen in instances in which the antigenic stimulation was by heterospecific 
pregnancies as was the case with R.G. 
The findings that P1-A substance absorbed most of the anti-B while P1-B re- 
moved very little of the anti-A from serum R.G. strongly suggested that much 
of the anti-B activity in the serum was due to cross-reacting  antibody. Ad- 
ditional support for this conclusion was the observation that the R.G. anti- 
bodies obtained from P1-B by galactose elution manifested as much anti-A as 
anti-B activity (Table III). The occurrence of cross-reacting antibodies in the 
serum of some type O individuals has been documented repeatedly (35, 36). 
Evidence suggests that the specificity of these  antibodies  is directed against 
structural  features common  to  both  blood  group A  and  B  oligosaccharide 
determinants (37). 
The antibody yield resulting  from acid elution of P1-BGS (Table  III) was 
poor; this is in agreement with the observations of Kochwa and Rosenfield (38) 
who recovered very little antibody when anti-A- or anti-B-sensitized red cell 
stroma were treated with pH 3.0 glycine buffer. In contrast, GalNAc anti-A 
eluates were found to contain as much as 70 % of the total antibody N absorbed 
onto P1-A. Antibody yields may be improved even further if larger  haptens 
such as A5II or ART. 0.52 were used for elution. 
The presence of ~/M-, ~/G-, and ^/A-immunoglobulins in the Ortho and R.G. 
eluates confirms  the  observations  of Kunkel and Rockey (8),  Rawson and 
Abelson  (9), and Ishizaka, et al.  (10), that, in individual human sera,  iso- 
hemagglutlnins may occur  in  all  3  immunoglobulin  classes. As  previously 
described,  the concentrated Ortho eluate contained an additional unidentified 
protein that migrated in the slow E-region on immunoelectrophoresis. Whether 
this represents  doubling of the ~,M-precipitin line due to K and L determinants 
or an additional component could not be determined. 1076  HUMAN  ANTIBODIES. IV 
Except for the 19S 7M-cold agglutinins, of which all reported examples have 
been type K  (39, 40),  a variety of purified  human antibodies (TG as well as 
"yM) have been found to contain both K  and L  light chain determinants in 
varying proportions.  Thus, Mannik and Kunkel (41) observed that 6 purified 
anti-A and 2 anti-B antibodies exhibited both K and L determinants; of these 
antibodies 6 were primarily 7G, one "i,M, and one 3'A. Similar  findings have 
been reported for other human antibodies including anti-Rh  (40, 41),  anti- 
thyroglobulin (41),  antiteichoic acid (41), and rheumatoid factors (39).  The 
present studies differ from  the previous ones  in  that  antibodies of a  given 
specificity were separated into 7M- and "rG-fractions and the L chain determi- 
nants of the latter compared. Both type K and L molecules (with a preponder- 
ance of L) were found in the two Ortho fractions. The R.G. 7M-fraction also 
contained both light chain determinants and in this antibody fraction type K 
molecules appeared to predominate. In striking contrast, the R.G. 7G-fraction 
was essentially devoid of type L determinants, being made up of type K mole- 
cules almost exdusively. Although this finding is of unusual interest, its signifi- 
cance cannot be fully assessed. It is generally believed that a single antibody- 
producing cell may synthesize either, but not both,  type K  or type L  light 
chains (42). If, as proposed by Nossal et al.  (43), individual antibody-forming 
cells synthesize first 7M- then 7G-antibodies of a given specificity,  the anti- 
bodies produced, regardless  of their configuration,  would contain a relatively 
fixed proportion of K and L light chains. Since, the 7M- and 7G-immunoglobu- 
lins isolated from serum R.G. differed significantly in this respect, the following 
possibilities  must be considered: (a)  a  selected population of 7M-producing 
cells (principally L chain formers) failed to produce 7G; (b) 7G- and 7M-anti- 
bodies of the same specificity are synthesized in different cells; or (c) the purifi- 
cation procedures employed resulted in the isolation of selected, phenotypically 
distinguishable  populations of TM- and "yG-immunoglobulins. The last alterna- 
tive is discussed subsequently in another context. 
The purified anti-A antibodies obtained from the Ortho and R.G. sera were 
incompletely precipitable by hog A  substance  (Tables III and IV).  Similar 
findings have been reported previously with purified human antidextrans (25). 
Why the homologous  antigens do not totally precipitate these purified anti- 
bodies is not understood. The problem in part involves difficulties in the analysis 
of very small amounts of antibody by the ninhydrin method (cf. 25, footnote 
to Table I). It is possible that such antigen-antibody complexes are unusually 
soluble  or that the antibodies undergo structural changes during purification 
which render them less precipitable.  The importance of solubility factors is 
emphasized by the results of the gel diffusion study illustrated in Fig. 1 D. The 
concentrated unfractionated, R.G. anti-A eluate placed in the center well was 
found, by quantitative precipitin analysis to be 71%  precipitable by hog A 
substance (Table III) but the precipitin bands formed by the eluate and blood MANUEL  E.  KAPLAN  AND  ELVIN  A.  KABAT  1077 
group A substances were extensively penetrated by the "yG-anti-~,G, "yM-anti- 
~M, and -¢A-anti-~A  precipitin lines. This indicates that A-anti A precipitation 
in agar at 37°C is less  complete than  that  occurring under conditions of the 
quantitative precipitin assay. The A-anti A  complexes  in  agar at 37°C would 
appear to be significantly  more soluble or dissociable  than the immunoglobulin- 
anti-immunoglobulin precipitates. 
The observations indicating that the purified ~,G-anti-A antibodies are, on a 
molar basis as active, if not more active, than "yM-antibodies  in agglutinating 
human type A1 red cells (Table IV) are at variance with previously published 
studies (10, 44). Ishizaka, et al.  (10), measuring specific antibody content by 
indirect methods, estimate that  the n~inln~um levels of human  anti-A in im- 
munoglobulin concentrates required to induce hemagglutination  are,  for "¢M, 
0.0004 to 0.000g ug AbN/ml, and for wG, 0.01 ttg AbN/ml, AbN concentrations 
being determined by uptake of radioactive iodine.  The present studies suggest 
minimal hemagglutinating concentrations of 0.39 and 0.43 #g N[ml for ~'M and 
0.03 and 0.21/~g  N/m1 for ~,G--anti-A antibodies respectively. While the data 
for wG-antibodies are in substantial agreement,  those for the "yM-antibodies 
differ by a factor of 1000. The reasons for this are not immediately apparent. 
It is possible that  GalNAc elutes only weakly binding,  poorly agglutinating 
,yM-anti-A from P1-A, while the more strongly binding,  actively agglutinating 
~,M-molecules resist elution and are not recovered or studied. 
The capacity of haptens of various sizes to inhibit precipitation of antibody 
by homologous antigen  (quantitative hapten inhibition technique) is believed 
to reflect the degree to which the haptens conform to the antibody-combining 
site  (cf.  18).  Thus,  after it was demonstrated with  several antidextran  sera 
having  1,  6  specificity that  isomaltohexaose  or isomaltoheptaose were,  on a 
molar basis, the most efficient inhibitors of dextran-antidextran  precipitation, 
it was inferred that the maximum size of the antibody combining site was in 
the range of a hexa- or heptasaccharide (45). 
By performing such studies with ~/M- and  ~G-anti-A  antibodies isolated 
from individual sera it was hoped to elucidate and compare the combining site 
characteristics of these two antibody classes. It was found that the precipitation 
of ~G-anti-A fractions was most effectively inhibited by the pentasaccharide 
hapten ART.  0.52 while the ~,M-antibodies from the same sera were inhibited to 
the same degree by equimolar concentrations of monosaccharide (GalNAc), tri- 
saccharide,  and pentasaccharide haptens. These findings suggest that the anti- 
body-comblning sites  of  these  isolated  immunoglobulin  fractions  differ,  the 
,yG-sites  being sufficiently  large to accommodate, at least,  a pentasaccharide 
while the capacity of the smaller  wM-sites is limited to GalNAc, the terminal 
nonreducing sugar of the A-antigenic  determinant. 
The question arises as to whether the small  combining site size of the WM- 
anti-A is characteristic of all ~,M-anti-A molecules or whether the method of 1078  RUAN  ANTIBODIES.  IV 
isolation involves some selection of molecules with smaller size combining sites. 
Some evidence of selection is apparent in comparing the whole serum with the 
eluates as well as with the separated ~,M- and ~,G-fractions (Figs. 2 and 3). 
Since the available data indicates that "},M-antibodies  have a  valence of five 
or six (46,  47)  while ~/G-antibodies are bivalent, it is quite possible that the 
GalNAc extraction of the polyleucyl BGS-anti-A precipitate eluted only "rM- 
antibodies with small combining sites, e.g. complementary to  GalNAc, while 
simultaneously extracting  a  more  representative  sample  of  the  ~'G-anti-A. 
This,  as noted above,  could account for the  observed differences in hemag- 
glutinating potency for the "~,M-anti-A in this and other laboratories. Further 
information on this point will become available when extracts are made with 
larger haptens such as the pentasaccharide. 
Evidence that combining site heterogeneity does, in fact, exist among the 
TG-anti-A immunoglobulin molecules present in an individual serum is seen in 
Figs. 3  and 4.  A5II,  the  trisaccharide hapten, inhibited precipitation of the 
Ortho TG-fraction to a  degree intermediate between GalNAc and the penta- 
saccharide hapten AR~ 0.52. This suggests that more ~,G-molecules  are able to 
react with the trisaccharide than with GalNAc alone and that when fucose is 
linked to the subterminal galactose of the trisaccharide (forming a  branched 
ollgosaccharide), antibody binding is again substantially increased. With re- 
spect to the R.G. ~/G-fract~on,  in contrast,  the  trisaccharide hapten was no 
more inhibitory than was GalNAc. These differences are quite consistent with 
earlier interpretations (cf. 17, 48) of the role of the fucose side chain on the sub- 
terminal galactose of AR~ 0.52  in increasing the inhibiting power of the tri- 
saccharide hapten by stabilizing a preferred conformation of the A determinant. 
Evidence for preferred conformations of oligosaccharides containing GNAc and 
GalNAc in solution has been obtained by optical rotatory dispersion studies 
(48). 
SUMMARY 
Insoluble blood group substances prepared  by copolymerization of soluble 
blood  group  substances  with  N-carboxy-L-leucine  anhydride  were  used  to 
absorb blood group antibodies from two human, high-titered anti-A sera. After 
the  absorbants were washed free of nonspecific serum proteins,  blood group 
antibodies were eluted either with pH 3.62 acetate buffer, or at neutral pH with 
monosaccharide haptens  of the  A  or  B  antigenic determinants  (N-acetyl-D- 
galactosamine or D-galactose  respectively). The purified anti-A antibodies were 
characterized,  immunoelectrophoretically,  as  ~/M-,  ~/A-, and  ~G-immuno- 
globulins.  These  were  further  separated  into  ~,M-  and  3,G-fractions by  gel 
filtration or density gradient centrifugation. Both ~,M- and one of the two ~/G- 
antibody fractions contained K  and L light chain determinants; the remaining 
~,G-fraction was comprised, almost totally, of type K  molecules. MANUEL E.  KAPLAN AND ELVIN A.  KABAT  1079 
Precipitability of the  purified anti-A  immunoglobulins  by blood group  A 
substance varied from 43 to 89 %. The agglutinating activity per unit N  of the 
isolated ~'G-anti-A was found to equal, in one case, and to exceed, in the second, 
that of the "yM-antibodies from the same individuals. 
The marked differences between "},M- and "yG-antibody fractions in quanti- 
tative hapten inhibition studies were interpreted to mean that the antibody- 
combining site of the isolated eluted h,G-anti-A was significantly larger than 
that  of  the  eluted  TM-anti-A.  Whether  these  data  connote  differences in 
combining site  size  between  entire immunoglobulin  classes  in  an  individual 
serum or simply reflect the properties of highly selected antibody populations 
cannot be stated at present. 
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